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ABSTRACT 
Mycobacterium tuberculosis (MTB) is the bacterium that is the causal agent of 
tuberculosis. MTB is estimated to infect one-third of the world's population. The 
emergence of multi drug-resistant and extensively drug-resistant strains of the bacterium 
are becoming a larger threat to global health as they decrease the efficacy of current 
treatments and make the disease more fatal. These factors combine to make MTB an 
interesting target for study with novel systems biology approaches. Genome-scale 
metabolic models have emerged as important platforms for the analysis of datasets that 
describe highly-interconnected biological processes. We have the first comprehensive 
profiling of mRNA, proteins, metabolites, and lipids in MTB during an in vitro model of 
infection that includes a time course of induced hypoxia andre-aeration. Hypoxia and re-
aeration are in1portant cues during infection of the human host and act to model the 
environment seen in the host. We use genome-scale metabolic modeling methods to 
integrate these data with our metabolic model will allow us to generate experimentally-
testable predictions about metabolic adaptations that occur in response to experimental 
perturbations that represent an in vitro model of important environmental cues present 
during infection, dormancy, and re-activation in the human host. 
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GENERAL INTRODUCTION 
Background and significance 
In conjunction with signaling and transcriptional regulatory networks, metabolic 
networks enable microbes to inhabit an astonishingly diverse set of niches and to rapidly 
adapt to changes in the surrounding environment. The development of relatively cheap 
sequencing approaches and the common use of high-throughput genomics profiling 
techniques has led to a proliferation of studies that address changes in regulatory and 
metabolic state at the genome scale. In particular, recent years have seen the development 
of genome-scale metabolic models from sequencing data and manual and automated 
model reconstruction techniques. These models provide scaffolds that allow for the 
integration of genome-scale profiling data (including transcriptomics, lipidomics, 
glycomics, and metabolomics) in order answer many standing questions about microbial 
and, recently, human metabolism. In particular, Mycobacterium tuberculosis (MTB) is an 
important target of such methods because of the length of its doubling time (24 hours in 
aerobic conditions) and because of its BSL 3 designation, both of which slow the rate at 
which experiments can be completed and which necessitate careful planning. Metabolic 
modeling approaches should greatly aid our ability to perform meaningful research in 
MTB. 
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Metabolism of Mycobacterium tuberculosis 
Mycobacterium tuberculosis 
Mycobacterium tuberculosis (MTB) is the bacterium that is the causal agent of 
tuberculosis (TB). MTB is estimated to infect one-third ofthe world's population [1] . The 
emergence of multi drug-resistant and extensively drug-resistant strains of the bacterium 
are becoming a larger threat to global health as they are less susceptible to currently-
available antibiotic treatments and can show increased rates of death in infected 
individuals [2] . These factors combine to make MTB an interesting target for study with 
novel systems biology approaches. 
Foamy macrophage 
Lymphocyte 
1 Macrophage 
Figure 1 Structure of the granuloma 
Mycobacterium tuberculosis lives inside the granuloma, a structure that forms as 
immune cells accumulate as part of the innate immune response. The center of 
this granuloma becomes increasingly hypoxic as cells gather and a fibrous cuff 
forms to encase it. 
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MTB that is inhaled into the lung is able to grow unabated for days or weeks within the 
phagosomes of alveolar macrophages until an adaptive immune response is mounted. 
Upon activation of both macrophages and other components of the host immune system 
via cytokine production, organized structures called granulomas are formed that lead to 
the suppression ofMTB replication [3,4]. This limitation of growth in the phagosome is 
thought to be the result of exposure to hypoxic conditions, nutrient deprivation, and low 
pH, among other factors [3,5,6]. Figure 1 shows a schematic of the structure of a 
granuloma after monocyte recruitment and differentiation of the macrophages of the 
granuloma into the various cell types that surround core of the structure. The 
advancement of the infection past this stage can lead to decreased oxygen tension in a 
decreasingly vascularized and more caseous center. 
The response of the bacteria to a changing environment subsequent to infection involves 
patterns of changes in the transcriptional and metabolic programs that are not yet fully 
understood. Extensive research into TB pathogenesis has highlighted the role of hypoxia 
in the granuloma as a key factor in the ability of MTB to survive in vivo [ 4, 7 -9]. 
Although conditions inside the macrophage slow or halt the growth of the bacteria, MTB 
remains metabolically active in orderto maintain the production ofNAD and ATP and to 
maintain the proton-motive force [10-12]. In this state of reduced metabolic and 
replicative activity, MTB can survive for periods ranging from months to decades 
without inducing symptoms in the human host [12]. A study by Rustad et al. [3] 
identified a set of genes that forms an enduring hypoxic response (EHR) that were not 
induced before the introduction of hypoxia and that are significantly up-regulated after 
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four to seven days of hypoxia. When this set of genes is analyzed for significant 
enrichment of functional categories many metabolic pathways are present including 
intermediary metabolism and respiration, cell wall and cell processes, and lipid 
metabolism. 
Re-aeration is also an important environmental cue for metabolic adaptation in MTB. 
This process, which is not as well studied as the role of hypoxia, triggers a return to a 
replicating state by MTB. Sherrid et al. [12] studied the effect of the return of oxygen to a 
rolling culture of MTB. They found transcriptional modification of several metabolic 
genes, including genes involved in fatty acid metabolism, sugar transport, and a 
triacylglycerollipase. These changes accompanied a return to a replicative state. In 
addition, the up-regulation of chaperone proteins and proteases suggest that important 
changes are occurring to a cell wall that was thickened during hypoxia [13]. 
While many studies have looked into the roles of hypoxia andre-aeration in bacterial 
metabolic adaptation during infection, important questions still remain about exactly how 
changes in metabolism during transitions into dormancy and then back in to replication 
and specifically, how these changes are manifested as reconfigurations of metabolic flux. 
Another important thrust of research into the biology of Mycobacterium tuberculosis is in 
the development of experimental models that utilize host cell culture techniques in order 
to approximate the intracellular macrophage environment that the bacterium sees inside 
the macrophage cells of the lung. MTB is able to evade elimination during infection by 
modifying the endocytic network of the macrophage in order to prevent fusion of the 
4 
phagosome in which it resides to the lysosome [14]. Little is known about why this 
occurs. In addition, there is still much to be discovered about the metabolism of MTB 
within the macrophage. Further understanding of which carbon sources the bacterium 
sees throughout its lifecycle in the host and the metabolic pathways that are activated 
would contribute to the development of novel treatments for infection [ 15]. 
Much work is currently being conducted and recent advances in understanding central 
carbon metabolism have improved our knowledge of central carbon metabolism in MTB 
[ 16] . These advances have improved our ability to use experimental and computational 
metabolic models to query the changes that this bacterium undergoes during infection of 
human host cells and in experimental models of induced hypoxia and re-aeration. 
Metabolic Modeling 
Computational analysis of genome-scale metabolic models has shown promising results 
when employed in an effort to understand the metabolism of Mycobacterium tuberculosis 
[ 17-24]. These efforts are complemented by a large number of computational studies into 
the metabolism of both non-pathogenic and pathogenic bacteria [ 17, 19-29]. These efforts 
are complemented by a large number of computational studies into the metabolism of 
both non-pathogenic and pathogenic bacteria [25-28]. 
Flux balance analysis (FBA), a method used to analyze metabolic activity in genome-
scale metabolic models, represents a metabolic network by capturing the stoichiometries 
of constituent reactions in a stoichiometric matrix S. This matrix, along with constraints 
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on the upper and lower bounds of the reaction velocities (which may be estimated, 
measured experimentally, or calculated from thermodynamic constraints), define the set 
of all possible reaction rates in a genome-scale metabolic model. By defining a metabolic 
objective function that is a linear combination of the values of the metabolic fluxes, linear 
programming can be used to optimize this function and thus select one (or more) flux 
configuration(s) as the optimal solution for a chosen metabolic goal (often defined as the 
maximization of the production of biomass). A technique called linear programming is 
used to define these flux configurations and can be described by the following problem, 
where the value of the objective function is Z, the metabolic flux vector is v, and the 
lower and upper reaction bounds are lb and ub: 
maximizeZ 
Subject to S · v = 0 
lb::;; v::;; ub 
Equation 1: Flux Balance Analysis 
Here, Z is an objective function to be maximized and varies depending on the model and 
the conditions to be simulated. The upper and lower reaction bounds limit the reaction 
velocities (or fluxes) that can be considered as solutions. Flux balance analysis relies on 
the utilization of constraints that limit the flux through some reactions by defining their 
minimum or maximum reaction rates. These become the upper and lower bounds on the 
reactions for which these values are known. Generally, these bounds are determined by 
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measuring reaction fluxes through uptake reactions, defining them from physical 
parameters (e.g. from diffusion constants), or calculating them from thermodynamic 
constraints. The set of constraints on the model define a flux cone that contains the set of 
feasible reaction rates for the constrained model. Figure 2 illustrates the effects of both 
the introduction of constraints on the feasible flux space and of optimizing for a given 
biological objective function. 
Several genome-scale metabolic models of Mycobacterium tuberculosis are currently in 
use. These models can be used in conjunction with FBA in order to give insight into the 
metabolic functionality ofMTB when subjected to knockout analysis, drug treatments, or 
when subjected to conditions that attempt to model host cell culture in silica [ 17-
20,24,29 ,30]. 
Integrating Experimental Data with Metabolic Models 
Previously, members of our group developed a method called E-Flux [29] that allows a 
modeler to directly integrate gene expression data from various conditions in order to 
make predictions about the effect of changes in transcriptional activity on metabolism. 
Colijn et al. used E-flux Figure 2 to correctly predict the effects of various environmental 
perturbations, drug treatments, and carbon sources on the production of mycolic acids 
using a compendium of gene expression data [31]. The predictions made by E-flux and a 
comparison with experimental data is shown in Figure 3. In E-flux, reaction bounds in a 
metabolic flux model are calculated directly from gene expression data collected from a 
condition of interest. 
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Figure 2 E-flux method 
Predicted Flux 
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Applying expression 
constraints reshapes 
the flux cone 
E-flux works by calculating maximum reaction flux bounds on a pathway model 
directly from expression data, which leads to a condition-dependent set of reaction 
flux solutions. 
Another method for the incorporation of gene expression data into metabolic flux models 
was developed by Shlomi et al. [32]. Unlike E-flux, this method doesn't rely on 
constraining reaction bounds directly based on the expression of the corresponding genes. 
Instead, a mixed integer linear programming (MILP) formulation is utilized that 
generates a metabolic flux distribution that maximizes consistency of the flux predictions 
with the gene expression data. The objective function rewards the activation of reactions 
with corresponding genes that show high expression and the inactivation of genes that 
have corresponding genes with low expression. Becker and Palsson [33] followed a 
similar tack to incorporate gene expression data but rely utilize a continuous weight for 
the utilization of a reaction that is based on the distance from an arbitrary threshold 
expression for high expression. 
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Figure 3 E-flux mycolic acid predictions 
E-flux was previously used to calculate relative maximal mycolic acid flux from a 
large expression compendium. The method correctly predicted 6 of 7 known 
inhibitors and 7 novel modulators of mycolate synthesis 
In addition to methods that utilize expression data in order to generate constraints on the 
utilization of reactions in a model, there have been several attempts at incorporating 
metabolomics data. The simplest of these methods entail the constraint of external 
exchange reactions, an approach taken by Mo et al. [34]. They utilized extracellular 
metabolomics measurements from perturbations of ammonium assimilation pathways as 
constraints on extracellular fluxes and flux space sampling in order to gain insight into 
potential flux solutions for those conditions. Ahn utilize a similar method to study the 
metabolic effects of knocking out organic anion transporter [35] . The authors apply 
extracellular metabolomics constraints and analyze transcriptomics data from the same 
knockout separately using the method of Becker and Palsson [33]. They then combine 
these results to find overlapping predictions. What sets these approaches apart is that, in 
contrast with the typical flux balance approach described previously, they either 
maximize a biological objective function while also maintaining consistency with the 
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data or they include as their sole objective the consistency of flux with the integrated data 
sets. While these methods represent substantial progress towards the utilization of 
overlapping genomics profiling datasets to constraint genome-scale metabolic models, 
there is still a need for effective metabolic modeling techniques that can combine 
multiple high-throughput -omics from a given condition using one approach. 
Finally, there are two studies which approach perhaps most closely address directly the 
question of if a non-thermodynamics-based flux balance analysis approach can be used to 
predict changes in metabolite concentration. In the first, a model of Plasmodium 
falciparum was used to predict changes in concentration of intracellular metabolites 
during the ring to trophozite and trophopzite to schizont phases of that organism's life 
cycle. Reznik, Mehta, and Segre apply expression data collected from a study of the 
metabolic changes during the yeast cell cycle to accurately predict changes in 
concentration during the shift from oxidative metabolism to reductive metabolism and 
building [36]. More importantly, these authors show that a particular property of the 
constraint-based linear programming approach, the shadow price, is broadly predictive of 
not only concentration changes but of metabolites that are growth-limiting in various 
nutrient-limited cell culture conditions across multiple nutrient-limiting conditions. These 
studies suggest the power of combining high-throughput data sets with metabolic models 
in order to make novel predictions about adaptations to environmental stresses. 
10 
MODELING LIPID METABOLISM IN MYCOBACTERIUM TUBERCULOSIS 
Introduction 
Several metabolic reconstructions designed for use with the FBA have been published. 
The first of these was published in 2005 by Raman et al. [ 17]. It is a detailed description 
of the mycolic acid pathway, which is the target of some front-line anti-tubercular drugs 
and plays a role in MTB virulence. This was followed 2007 by two-genome scale 
metabolic models by Beste et al. [19] (designated GSMN-TB) and Jamshidi et al.[20] 
(designated iNJ661). GSMN-TB contains 849 reactions, 739 metabolites, and 726 genes. 
In the original publication, it achieved 78% accuracy on a set gene essentiality 
measurements. iNJ661 contains 939 reactions, 740 metabolites, and 661 genes. This 
model performed less accurately on the same gene expression essentiality data (55% 
accuracy) but was able to make accurate quantitative predictions of growth rate on 
several in silica media formulations. Both of the genome-scale metabolic models consist 
of biomass functions that are based on measurements on dry weight biomass composition 
measurements conducted in the closely-related organism Mycobacterium bovis BCG 
(BCG) during chemostat growth [37]. Both models contain detailed descriptions of 
glucose and glycerol metabolism as well as lipid degradation and production pathways. 
In the following chapter, we describe the justification for utilizing the GSMN-TB model 
for studies of mycobacterial metabolism. In addition we describe the work we have 
undertaken in order to ensure that the pathways representing lipid metabolism represent 
the current state of knowledge in the literature. We show that these efforts maintain high 
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accuracy in terms of gene essentiality predictions and improve our ability to use the 
model for further studies of mycobacterial lipid metabolism. 
Methods 
Updating the GSMN-TB model 
We have chosen to utilize the GSMN-TB model published by [19] and recently updated 
[38]. As originally published, the model consisted of 849 reactions, 739 metabolites, and 
726 genes. The model was converted from the SurreyFBA format [39] for use with the 
COBRA toolbox [ 40] by converting each transport reaction into two reactions: one 
transport reaction the converts between an external metabolite and a cellular metabolite 
and an exchange reaction. 
Published scientific literature was used to compile a list of genes and reactions found to 
be important in both central metabolic pathways and in lipid production and degradation. 
We have modified reactions and gene associations ofTCA cycle, updated the model with 
a cholesterol degradation pathway, and modified sulfolipid, triacylglycerol, 
diacylytrehalose, and polyacyltrehalose pathways so that they represent the current best 
known biochemical models. 
Predicting gene essentiality 
In order to assess gene essentiality, we utilized the flux balance analysis (FBA) method 
and tools provided by the COBRA toolbox forMA TLAB [ 40]. In vitro Gene essentiality 
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data is taken from a transposon site hybridization (TraSH) data set [ 41]. This dataset 
serves as the gold standard gene essentiality data set for Mycobacterium tuberculosis 
grown in vitro . For in silica studies, 7H9 medium was used with the minimal biomass 
composition "BIOMASSe" which includes major biomass components but lacks some 
components found to be dispensable in vitro [ 19]. 
Results 
There are currently many different published metabolic models of Mycobacterium 
tuberculosis [17,19,24,38,42]. In this work, we focus our modeling efforts on the GSMN-
TB model published by [19]. This model has proven to be well-suited to both in vitro and 
in vivo metabolic modeling studies [29,43] . It also contains more detailed descriptions of 
the lipid production pathways that contribute to the incredible success ofMTB as an in 
vivo human pathogen. The GSMN-TB model accurately predicts growth rates on glycerol 
and performs much better with respect to gene essentiality predictions when compared to 
the iNJ661 model of [ 42] (with 78% accuracy, 71% specificity, and 80% sensitivity for 
GSMN-TB and 55% accuracy for iNJ661). Recent work has improved the agreement of 
this model with in vivo gene essentiality data but GSMN-TB still more accurately models 
in vitro gene essentiality [24]. 
In order to integrate GSMN-TB with the modeling functions of COBRA, we began by 
converting transport reactions into two reactions: transport and exchange reactions. In 
addition, we made several modifications to the model in order to ensure that gene names 
matched the current genome annotation. We found several discrepancies between model 
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gene names and gene annotations and these were corrected. We then ran gene knockout 
analysis to ensure the consistency of our predictions with in vitro TraSH essentiality data. 
Receiver operating characteristic (ROC) curves are shown in Figure 4. As in the original 
reference [19] we choose values for the TraSH threshold for essentiality of0.05, 0.1, 0.2, 
and 0.5. These values correspond to the relative enrichment of the growth of each mutant 
after the pool of all transposon mutants was grown in the same medium condition. A 
mutant growth ratio of less than 1 indicates that that particular mutant is less fit than the 
wild type. Areas under the curve for ROC curves for ratios of 0.05, 0.1, 0.2, and 0.5 were 
0.74, 0.76, 0.77 and 0.73 respectively. Thus, our COBRA-compatible model provides an 
appropriate baseline accuracy for the addition of new biochemical and genetic 
knowledge. 
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Figure 4 ROC curve for GSMN-TB gene essentiality 
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Each curve shows a receiver operating characteristic curve for a different 
TraSH threshold and correspond to the curves plotted in [1]. Area under the 
curve ranges between 0. 73 and 0. 77 and are in line with those obtained in the 
original reference 
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Triacylyglycerol synthesis 
Before adding the additional cholesterol degradation pathway to the model, we first 
surveyed the literature for updates to existing model pathways. We begin with an 
assessment of the triacylglycerol (TAG) pathway. TAG is a storage lipid whose 
production is an important factor for the development of antibiotic resistance during 
dormancy in MTB [ 44] and whose utilization is essential for the regrowth of non-
growing BCG in hypoxic culture [ 45]. In an important work, Daniel and colleagues 
identified 15 genes with putative TAG synthesis activity. The gene Rv3130c (tgsl) was 
identified as having the highest activity when expressed in E. coli and shows the greatest 
induction upon exposure to hypoxia and NO treatment, both of which are linked to 
increased synthesis oftriacylglycerols in Mycobacterium tuberculosis. Accordingly, we 
have included this gene in the modified model as the main TAG synthesis gene. Beyond 
this, the current pathway including (diacylglycerol synthesis and triacylglycerollipase 
pathways) is consistent with the literature [44]. 
Sulfolipid synthesis 
Sulfolipids, specifically the sulfolipid identified as SL-1 in the literature, play an 
important role in the structure of the cell surface of MTB and have an important 
immunomodulatory role during infection [ 46]. Subsequent to the original publication of 
GSMN-TB, a series of papers has been published elucidating important steps in the 
sulfolipid production pathway and its important role in modulating the metabolism of 
MTB [46-51] . The current biochemical model that most closely matches experimental 
15 
results is reproduced in Figure 5. We have modified our model to correct gene 
associations for reactions associated with trehalose sulfation (stfO), the acylation of 
trehalose-2-sulfate (papA2), and the addition of a hydroxyphthioceranic acid to the newly 
acylated SL-1 precursor (pks2 and papAl). We then modified the model to more 
correctly represent the cell membrane scaffold and combined transport and synthesis 
model described in the literature [ 49,50]. In addition to these changes, we also addressed 
the genes associated with diacylytrehalose (DAT) and polyacyltrehalose (PAT) synthesis. 
PAT and DAT are branched chain lipids that, in conjunction with SL-1 are strongly 
regulated by the transcription factor phoP (Rv0757). By modifying the GSMN-TB model 
to include the most recent experimental knowledge of these pathways we are able to 
model the production of lipids important for their role in the contributing to the virulence 
ofMTB. 
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Chp1 
SL-1 transport to 
outer membrane 
? 
• periplasm 
MmpL8 Sap 
The current best model for sulfolipid synthesis is one in which Chp 1 (Rv3822) is 
embedded in the membrane and completes the synthesis ofSL-1. Mmpl8 (Rv3823c) 
and Sap (Rv3821) operate in conjunction to transport SL-1 across the membrane. 
(This research was originally published in The Journal of Biological Chemistry [50] 
© the American Society for Biochemistry and Molecular Biology 
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Cholesterol catabolism 
Recently, the role of cholesterol metabolism in Mycobacterium tuberculosis has been the 
subject of significant research effort. Metabolic flexibility during infection, persistence, 
and reactivation includes the ability for MTB to adapt to varying carbon source 
availability. There is experimental evidence that suggests that the utilization of host 
cholesterol is necessary for persistence following infection [52]. In addition, it has been 
shown MTB is able to grow in a medium with cholesterol as the sole carbon source [53]. 
Recently, a host of studies has been published describing attempts to elucidate both the 
metabolic and regulatory pathways that enable MTB to switch to cholesterol as a carbon 
source [54-61] and the potential metabolic impact [62,63]. 
Given the importance of this metabolic pathway in vivo, incorporated this pathway into 
our metabolic model of MTB. We have included reactions corresponding to the 
cholesterol transport from the medium, the catabolism of cholesterol's side-chain and of 
the degradation of the A, B, C, and D rings. While the degradation of the side-chain and 
the A and Brings is relatively well-characterized, the precise pathway for C and Dring 
degradation and the order in which side-chain and ring degradation occurs is not well-
characterized [64] . We have included a lumped reaction for C and Dring degradation 
with a gene-protein-reaction relationship and stoichiometry that is consistent with recent 
findings [60,61]. Our pathway is substantially similar to that in the newly modified 
GSMN-TB model so we have changed the reaction names in our model to better reflect 
the ones chosen for GSMN-TB 1.1 [3 8]. The current best model of cholesterol 
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degradation is show in Figure 6. 
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Figure 6 Overview of the mycobacterial cholesterol pathway 
Cholesterol degradation proceeds via P-oxidation after its conversion to a thioester 
(panel B). The assignment of specific genes to the pathway is hindered by the 
number of functionally-redundant enzymes in the mycobacterial genome. However, 
some steps in the pathway are well-characterized. C and D ring degradation are 
shown in panel A. The metabolic fate of9,17-dioxo-1,2,3,4,10,19-hexanoandrostan-
5-ioc acid (DOHNNA) is not entirely clear and a the exact number of pyruvate and 
propionate molecules produced has not been precisely measured. (Reproduced with 
permission from r 651) 
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In order to assess the accuracy of our model in predicting gene essential for growth on 
cholesterol as a sole carbon source, we utilized a newly-generated transposon site 
hybridization (TraSH) data set [59]. In this data set the relative enrichment oftransposon 
mutants when grown on cholesterol versus glycerol was measured through deep-
sequencing. For this analysis, we follow the method of the original authors and consider 
genes that show significantly decreased enrichment in cholesterol when compared to 
glycerol as specifically required for growth on cholesterol [59] . We consider genes that 
are specifically essential for growth on cholesterol to be those that show less than 50% 
optimal biomass yield after being in silica knockout. A false positive is a gene knockout 
that is predicted to be specifically required for growth on cholesterol but that shows a 
greater than 50% decrease in optimalbiomass yield during growth on glycerol. Table 1 
shows the contingency table that compares in silica predictions of genes specific to 
growth on cholesterol to experimental measurements. For the trash data set we see an 
accuracy of 96% with a specificity of 98% and sensitivity of 75%. This prediction is 
statistically significant with a p-value of 1.97e-35 according to Fisher's exact test. 
TraSH essential TraSH non-
essential 
in silico essential 33 18 
in silico non-essential 11 703 
Table 1 Predictions of genes specifically essential 
for growth on cholesterol 
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Of the 18 false positives predicted by our model, 5 are part of the newly-added 
cholesterol pathway. 4 of these are part of the insufficiently-described C and D ring 
degradation branch. It is clear that further work must be done in order to elucidate the 
role of the genes assigned to these reactions and do determine if partial degradation of 
cholesterol in absence of complete C and D ring degradation is sufficient to sustain 
growth. Other false positive genes are involved in both gluconeogenesis and lipid 
metabolism, suggesting that alternative routes may be available for downstream 
processing of cholesterol degradation products. 
Of the genes predicted as false negatives in our analysis, 6 are genes that encode enzymes 
catalyzing reactions upstream of phthiocerol dimycocerosate (PDIM) synthesis. The 
degradation products of cholesterol appear to be preferentially integrated into either 
PDIM [52] of SL-1 [ 63]. It has been shown that efforts at re-annotation of genes and 
metabolic pathways, in addition to further biochemical research may improve the 
representation of cholesterol metabolism in our model [65]. 
Global gene essentiality predictions 
In order to assess the overall agreement of our model with gene essentiality predictions 
after the modification of the lipid production pathways, we again ran gene essentiality 
prediction using flux balance analysis. Figure 7 shows the receiver operating 
characteristic curves that result from this knockout analysis. This analysis was performed 
for several TraSH ratio thresholds, as in [19]. For TraSH thresholds of0.05, 0.1, 0.2, and 
0.5 we achieve areas under the curve of0.76, 0.77, 0.79, and 0.75 respectively, 
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representing a moderate improvement over the original predictive capacity of GSMN-TB. 
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Figure 7 ROC curve for GSMN-TB gene essentiality after 
modification 
Each curve shows a receiver operating characteristic curve for a 
different TraSH threshold and correspond to the curves plotted in 
[19] 
Conclusions 
In this chapter, we have described modifications made to GSMN-TB in order to improve 
the representation of lipid production pathways in the model. The improved GSMN-TB 
model predicts genes specifically essential for growth on cholesterol as a sole carbon 
source with high specificity and sensitivity. In addition, we see modest improvements in 
gene knockout prediction capability. Although moderate, these improvements come with 
significantly improved correspondence of the representation of the model's lipid 
synthesis pathways with current biochemical knowledge. The improved model represents 
an important framework for generating predictions about the metabolic and 
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the ability of Mycobacterium tuberculosis to rapidly adapt to changing environments in 
the human host and in experimental models that mimic aspects of the host environment. 
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MODELING THE EFFECTS OF TRANSCRIPTION FACTOR 
PERTURBATIONS ON LIPID PRODUCTION IN MYCOBACTERIUM 
TUBERCULOSIS 
Introduction 
The ability for organisms to adapt to novel environmental cues is important for their 
success. Mycobacterium tuberculosis is particularly suited to survival in the human host. 
Its metabolic flexibility enables this successful pathogen to utilize the variety of carbon 
sources that it encounters and to survive the onslaught of hypoxia, increased pH, 
increased NO exposure, and the accompanying oxidative and nitrosative stress [3,6,8]. 
Metabolic flexibility follows from the transcriptional regulatory programs that translate 
signaling responses to both endogenous and exogenous cues. 
Several attempts have been undertaken to further our understanding of the transcriptional 
regulations of metabolism in MTB. These efforts include prediction of the effects of drug 
interventions on mycolic acid production [29], the regulation of growth in transcription 
factor knockouts [21], and the role of the hypoxia regulator dosR in hypoxic adaptation 
[66]. 
Here, we extend a previously-published metabolic modeling approach to couple gene 
expression data from experiments describing both transcription factor knockout and 
transcription factor overexpression experiments. We show that this method is able to 
accurately predict changes in lipid production a phoP knockout mutant. PhoP was 
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recently identified as binding strongly to DosR and WhiB3, both of which are important 
regulators of the response to hypoxia and changes in lipid metabolism [67], suggesting a 
role in hypoxic adaptation. PhoP, along with the aprABC locus that it has been shown to 
regulate, is also an important mediator of the response to low pH [ 68]. The central role of 
this regulator in the adaptation of stresses seen in the host makes it an important target for 
computation and experimental studies. 
We also revisit the dosR knockout expression data and show that we can improve on 
predictions of the regulatory role of dosR in lipid production during hypoxia. Previous 
work with this data set in a model of MTB captured important changes in oxygen uptake 
rates and reported wholesale changes in lipid metabolism after the induction of hypoxia 
for both wild type and dosR [ 66] . We revisit these predictions with an updated model of 
GSMN-TB and an adaptation of the PROM method for integrating gene expression data 
[21 ]. 
Methods 
M tuberculosis genome-scale metabolic model 
For all simulations, we made use of an update version ofthe GSMN-TB model [19]. The 
model was modified to included up-to-date representations of the production of the lipids 
triacylglycerol, diacylytrehalose, polyacyltrehalose, and of cholesterol degradation. 
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Transcription factor knockout data 
In this approach we utilize three previously-published high-quality gene expression array 
datasets. The first, described as part of the characterization of both a phoP knockout and 
knockouts of the aprABC region [68] and is accessible at the NCBI GEO database using 
accession GSE22854. This study compared the transcriptional responses of the CDC1551 
strain to that of a phoP transposon mutant. Each strain was grown to early log phase in 
standing cultures in 7H9 medium supplemented with OADC (bovine albumin, dextrose, 
catalase, and Tween-80). Transcript levels were measured from three experimental 
replicates. 
The second data set is from a study on the transcriptional response ofboth wild type 
MTB and a dosR knockout to the transition from aerobic growth to hypoxia [69] and is 
available with NCBI GEO accession GSE8829. In this study, an MTB wild type and 
dosR knockout strain were grown in roller bottles on 7H9 with OADC to mid-log. For the 
hypoxic samples, both wild type and dosR knockout samples were maintained at 2h at 
0.2% Oz in Nz. Subsequently, RNA was extracted as described in the manuscript [69]. 
Both of the two-color microarray datasets were analyzed using LIMMA [70] and 
MAANOVA [71], microarray analysis libraries for the R statistical programming 
language [72]. LIMMA was used to download datasets from LIMMA, for background 
correction using the normexp model, and for within-array normalization using the print-
tip loess method. After background correction and nonnalization, MAANOV A was used 
as described previously [29]. We used MAANOVA here to fit an analysis of variance 
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model of the form described in Equation 2. 
Yijkg = Uij + Gg + (AG) jg + (DG)ig + Ykg + Cijkg 
Equation 2: The analysis of variance model fit my MAANOV A 
As in the model used utilized for analysis of two-color microarray in theE-Flux 
framework [29], Yijkgdenotes the log-transformed measurement from the ith channel, jth 
chip, kth sample, and gth gene. Yijkg is the effect specific to sample kand gene g . 
Finally, Eijkgis the error. The model is fit to minimize the residual sum of squares 
RSS= Li,j,k,g Etkg · Yijkg is used as the main input for our metabolic modeling method. 
Overexpression data 
Cells were cultured in Middlebrook 7H9 with the ADC supplement (Difco ), 0.05% 
Tween80, and 50 f.lg/mL hygromycin Bat 37° C with constant agitation. All experiments 
were performed under aerobic conditions and growth was monitored by OD600. Total 
RNA was isolated from TF-induced cultures 18 hours after treatment with 100 ng 
Anhydrotetracycline (ATe) per mL of culture or an equivalent volume ofDMSO (in the 
case ofuninduced controls) using the protocol described in the transcriptomic section of 
this manuscript. When interrogating the same culture for ChiP-Seq and RNA profiling, 
cells were divided immediately prior to sample processing. In the case of biological 
replicate RNA samples, independent cultures were generated and transcription factor 
induction/RNA isolation was carried out as described above. RNA samples were profiled 
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using custom 12-plex NimbleGen microarrays (accessible with NCBI GEO accession 
number GPL14824). Each array on the slides consists of 105k probes tiled approximately 
every 100 bp over the genome. 
Gene expression data were nonnalized using the oligo library [73], which is available for 
the R statistical software package [72] . This library implements previously-described 
single channel microarray analysis methods for background correction, quantile 
normalization, and RMA probe summarization [74] . 
Metabolic modeling 
For our simulations of the metabolic effects of transcription factor knockouts, we utilized 
a method called probabilistic regulation of metabolism (PROM) method required 
modification for use with two-color microarray data sets. As described previously, 
condition-specific reaction bounds are generated from gene expression values of 
corresponding genes and from a set of baseline flux bounds calculated using flux 
variability analysis that represent the maximum bounds for each reaction in the model 
[21,75]. While many factors contribute to enzyme activity, PROM uses gene expression 
to approximate maximum reaction activity. 
Utilizing a modification of the gene expression sampling approach previously described 
as part of theE-flux framework [29], we calculated the predicted maximum production 
and maximum consumption of each metabolite of interest. The difference between the 
maximum predicted production and consumption we tenn the maximum flux capacity 
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Figure 8 is a schematic that represents the value that we calculate with PROM. As we do 
with extracellular metabolites and biomass components, we relax the steady-state 
assumption of FBA for each intracellular metabolite in tum in order to generate an 
estimation of its accumulation or utilization for each condition of interest. 
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Figure 8 Schematic showing the calculation of accumulation and degradation of 
intracellular metabolites 
A metabolite, named x here, takes part in both producing and consuming reactions 
in a model subject to constraints on nutrient uptake, waste secretion, and biomass 
production. In panel A, the flux through reactions producing X are in equilibrium 
and thus there is no accumulation of X. Panels B and C show situations where X is 
produced and consumed respectively. 
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We assess the variance of the production of each metabolite using a Monte Carlo 
approach. For each optimization we sample from a Gaussian distribution with mean zero 
and with a standard deviation calculated from the standard deviation of each gene at each 
time point across all microarray replicates. 
Expression values for each gene were normalized by the maximum value for each gene 
across the knockout and control channels. Condition-specific reaction bounds are 
calculated from gene expression values of corresponding genes and from a set of baseline 
flux bounds calculated using flux variability analysis that represent the maximum bounds 
for each reaction in the model [75]. 
Results and discussion 
Figure 9 shows an overview of how this analysis fits within a framework that enables us 
to make novel predictions of metabolic phenotype from knowledge of transcriptional 
regulatory and metabolic network models. For the purposes of this analysis we focus on 
the gene-protein-reaction relationships present in our model. Gene expression data is 
converted into bounds on the reaction rates of a flux balance analysis model. 
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Figure 9 Overview of the combined regulatory and metabolic modeling approach 
(A) Using ChiP-Seq, we have developed the first regulatory network map for MTB 
based on 51 TFs (red nodes) resulting in 5521 interactions (edges) between TFs and 
other genes. Using the network, we have developed quantitative models for 
predicting the dynamic expression of genes in the network as a function of TFs 
predicted to regulate each gene [67]. We to use these models to comprehensively 
predict the impact on gene expression of all TF knockouts. (B) We have developed a 
genome-scale model of the MTB metabolic network, and methods for integrating 
gene expression with this model [29,67,75-77]. We use these approaches to predict 
the metabolic impact of TF knockouts from the corresponding expression data 
PhoP knockout 
For our frrst analysis, we applied gene expression data from a phoP knockout [68,76] to 
our genome-scale model of Mycobacterium tuberculosis as described in Methods. PhoP 
is a transcription factor that, along with the locus aprABC, has been shown to impact 
cellular aggregation, growth inside macrophages, and to change the production of cell 
wall, virulence, and storage lipids [ 68]. We tested the maximum net production for eight 
lipid classes: triacylglycerol (TAG), mycolic acid associated with arabinogalactan 
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(MAPC), phthiocerol dimycocerosate (DIM), sulfolipids (SL-1), 
diacyltrehalose/polyacyltrehalose (PAT /DAT), trehalosedimycolates (TDM), and 
trehalosemonomycolates (TMM). We compared our predictions with several previous 
studies reporting measurements using thin-layer chromatography (TLC) of seven lipid 
classes [ 68,77, 78]. Out of these seven classes, we predict seven changes in production 
between the wild type strain and the knockout strain correctly. These results are 
summarized in Figure 10. 
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Figure 10 Changes in lipid production after the knockout of the regulator PhoP 
Here, we show predictions generated using the PROM method. Each prediction represents the fold 
change in net production of each lipid in the knockout relative to the wild type net production rate. We 
correctly predict 7 of 7 previously-known changes in production, including large changes in production 
of SL-1, PAT, and DAT, the genes of which are known targets ofPhoP. Error bars standard deviations 
calculated across 3 replicates. Statistical significance is calculated by comparison to a null model where 
samples from control channels only (wild type strain) are made. These comparisons serve as a null 
model distribution to which knockout predictions are compared. TAG, triacylglycerol; MAPC, mycolic 
acid; DIM, phthiocerol dimycocerosate; SL-1 , sulfolipid; PAT, polyacyltrehalose; DAT, 
diacyltrehalose; TDM trehalosedimycolates; TMM, trehalosemonomycolates 
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Figure 11 Coordinated production of branched-chain virulence lipids 
Sulfolipids (Sl-1), polyacyltrehalose (PAT), diacyltrehalose (DAT), and phthiocerol 
dimycocerosates (PDIM). PhoP directly regulates the pathways leading to SL-1 and 
PAT and DAT synthesis, but not PDIM. This suggests that we may successfully 
capture a flux-coupling phenomenon regulated by phoP. The right panel shows the 
structures of each of these lipid classes. They are important components of the 
external cell wall and are important for the modulation of the immune response of 
the macrophage during infection. 
Of particular interest are the predictions of decreases in SL-1, PAT, and DAT production 
and the increase in the production ofDIM. Figure 11 shows the relationship between 
these three lipid classes. PhoP directly regulates pks2 and pks3 , genes reponsible for 
sulfolipid (SL-1) production and polyacyltrehalose/diacyltehalose (PAT/DAT) 
production respectively. These lipids are important virulence lipids and an important part 
of the reponse to macrophage infection by MTB. PDIM appears to be specifically 
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required for growh in the lungs of mice [79] and, along with the other lipids, plays a role 
in the regulation of the redox state ofthe cell by acting as a shunt for the incoporation of 
reducing equivalents and propionyl-CoA [80] . It has also been shown that Sl-1 and PDIM 
production can be regulated by the availability of a their common precursors 
methylmalonyl-CoA and propionate [48]. Our model is consistent with a regulatory role 
for PhoP in fine-tuning the flux of these precursors to down-stream lipid production 
pathways. In particular, even in the absense of regulation of the genes in the PDIM 
production pathway we are able to capture the effects of altered flux through propionate 
metabolism due to the use of soft reaction flux constraints in the PROM approach. 
In addition, it is hypothesized. that the accumulation ofT AG may be the result of a 
decrease in the utilization of TAG rather than as a result of the up-regulation of 
triacyglycerol synthases [68]. Our computational model takes into account the role of 
differences in the maximum production and consumption in the model of each 
metabolite. Thus, we are able to address the question of the role of the regulation of 
downstream TAG catabolic pathways. In fact, althought we do not see significant 
differential expression of the TAG synthesis gene Rv3130c, we see that both TAG and 
upstream precursor metabolites are all predicted to show statistically significant increases 
in concentration by our model. In contrast, our model predicts a statistically significant 
decrease in the accumulation of glycerol, which is the downstream product of TAG 
degradation. This suggests that in the case ofthe phoP knockout, TAG accumulation is 
due to the regulation of the degradation pathway as opposed to the synthesis pathway. 
Thus, genetic regulation of the degradation rate of TAG may act in place of or in concert 
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with the proposed regulation ofthe TAG synthase gene Rv3130c by intracellular 
concentrations ofTAG [68]. 
DosR knockout analysis 
Figure 12 summarizes the key predictions of our model for gene expression data from a 
dosR knockout and a wild type MTB strain subjected to hypoxia. The expression data 
utilized in this analysis come from an experiment where each strain was subjected to 2 
hours of an atmosphere with 0.2% oxygen. Two-color microarrays were used to compare 
hypoxic transcription and normoxic transcription for each strain in triplicate. We 
performed PROM analysis for lipid production for each strain. The values in Figure 12 
represent the fold change in production when we compare our net production values 
between the dosR mutant and the wild type strain. The greatest difference by a large 
margin is in the production oftriacylglycerol. Rv3130c (tgsl) is the primary TAG 
production gene [81]. DosR has been shown to be required for the induction of the 
triacylglycerol synthase gene R v3130c [ 69] and is by far the strongest regulator, as 
determined by a combination of ChiP-seq and transcription factor overexpression 
experiments [ 67]. Thus, this prediction of a larger decrease in the production of TAG is 
consistent with the results of previous experiments. 
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Figure 12 Differences in lipid production in hypoxia between H37Rv and a dosR 
knockout 
Here, we show predictions generated using the PROM method. Each strain (wild 
type H37Rv and a dosR knockout) was subjected to hypoxic conditions and lipid 
production predicted. This graph shows the fold change in net lipid production 
between the dosR knockout and the wild type strain. The only significantly 
differentially produced lipid is TAG, suggesting that the change in production of 
other lipids may be much greater control by non-dosR transcription factors during 
the hypoxic transition. TAG, triacylglycerol; MAPC, mycolic acid; DIM, 
phthiocerol dimycocerosate; SL-1, sulfolipid; PAT, polyacyltrehalose; DAT, 
diacyltrehalose; TDM trehalosedimycolates; TMM, trehalosemonomycolate 
DosR overexpression 
In order to further validate the use of our modified GSMN-TB model and the PROM 
method for the analysis of perturbations of lipid production in Mycobacterium 
tuberculosis, we conducted an analysis of changes in lipid production after the induction 
of the transcription factor dosR. These data were collected by our collaborators using 
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single-channel Nimblegen microarrays, which are analyzed with different techniques 
(described in the methods) and that can be treated more directly as an estimate of 
transcript abundance. For our two-color microarray analysis we generated expression-
derived flux bounds by dividing each channel of each array by the maximum value of 
either channel. For the analysis of the overexpression data, we divide the RMA 
expression value of each gene by its maximum value across 290 chips. 
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Figure 13 TF overexpression experiments showing the highest levels of predicted 
TAG production 
TF overexpression experiments showing the highest levels of predicted TAG 
production: Here, we show the experiments from our overexpression data set with 
the highest levels of TAG production, normalized to the maximum production. The 
top 8 experiments are dosR overexpression experiments and 12 out of the 25 
experiments showing the highest levels of TAG expression. Experiments highlighted 
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in blue are dosR overexpression experiments. 
Figure 13 shows predicted levels of TAG production for the 25 experiments with the 
highest production levels. The top 8 experiments are dosR overexpression experiments 
and 12 out of the top 25 experiments showing the highest levels of TAG production are 
dosR overexpression experiments. Interestingly, although induction oftgs1 expression 
seems to be the driving factor for increases in TAG production, several transcription 
factor overexpression experiments seem to have relatively large effects on TAG 
production. 
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Figure 14 Predicted lipid production in dosR overexpression experiments 
TMM 
In order to examine the effect that dosR overexpression has on other lipids, we examined 
the production ofTAG, MAPC, SL-1 , PAT, DAT, TDM, and TMM in those experiments 
where dosR was most highly induced (ATe concentrations were 100 ng I mL) and where 
cultures were held in normoxic conditions. In this way we can reduce the confounding 
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effect of hypoxic response transcription factors other than dosR in our analysis of the role 
of dosR in regulating lipid production. Figure 14 shows the results of this analysis. 
Interestingly, we see not only an induction of TAG but a significant decrease in MAPC 
and PDIM. These changes are consistent with decreases in the production of mycolates 
and PDIM observed in lipidomics measurements across a hypoxic time course [67]. This 
prediction is also consistent with the strong regulation of papAS (Rv2939), which is an 
acyltransferase that is involved in the production ofPDIM [82]. In addition, in ChiP-seq 
data binding data published by our lab in combination with the overexpression 
microarrays predict the regulation of genes coding for proteins that transport intracellular 
PDIM to the external cell wall. 
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Figure 15 Predicted regulatory submodule for the regulation of PDIM synthesis by 
dosR 
(A) The genes predicted to be regulated by dosR according to our ChiP-seq and 
overexpression datasets. Blue lines highlight negative regulation (B) The mean 
expression of each of the genes in (A) in terms of their z-scores calculated across all 
overexpression experiments. Error bars show the standard deviation of the z-score 
across the dosR overexpression experiments. 
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Although the role of dosR in the regulation oftriacylglycerol is well known, the role of 
dosR in the regulation ofPDIM synthesis is less well-studied. It has been observed that 
PDIM concentrations in the cell decrease moderately upon the introduction of hypoxia 
and then return to normal levels after re-aeration [ 67] . Figure 15 shows a predicted 
regulatory submodule for the regulation ofPDIM synthesis by dosR. 
Conclusions 
Here, we have utilized GSMN-TB, a genome-scale metabolic model of Mycobacterium 
tuberculosis [ 19], and the PROM method for the integration of gene expression data with 
genome-scale metabolic models [21] in order to test the ability for the model to make 
accurate predictions about changes in lipid production after the perturbation of the 
transcriptional regulatory network ofMTB. We show that our method enables us to make 
accurate predictions about the regulation ofboth triacylglycerol (TAG) and branched 
chain lipid synthesis in a knockout of the pH-response transcriptional regulator phoP 
(Rv0757). We also accurately predict a decrease in the production of TAG after the 
knockout ofthe regulator required for its production, dosR (Rv3133c). We also predict 
that overexpression of dosR leads to a significant decrease in the production of 
phthiocerol dimycocerosates (PDIM), an important virulence lipid that mediates the 
immune response of human cells during infection. Finally, we make a novel prediction of 
the regulatory subnetwork via which dosR may regulate the metabolism ofPDIM. 
The accuracy of our predictions suggests that GSMN-TB in combination with PROM 
may serve as a platform that enables us to study the transcriptional and metabolic 
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regulation of lipid production using data describing both the perturbation of other 
elements of the transcriptional regulatory network of MTB but also using data collected 
from cultures that are designed to mimic aspects of the environment experienced by MTB 
during infection. Environmental perturbations shown to be important during infection 
include hypoxia [8], low pH [68], increased nitrosative stress, and increased oxidative 
stress [80]. The benefit of accurate modeling of these environments would be significant 
given the lengthy doubling time ofMTB, which necessitates accurate predictions from 
computational models, and the increasing complexity of the data sets being generated 
from experimental models ofMTB [67]. 
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MODELING METABOLISM ADAPTATIONS TO HYPOXIA AND RE-
AERATION 
Introduction 
In previous work in our lab, we described experimental methods designed to study the 
transcriptional and metabolic changes that accompany hypoxia andre-aeration [67]. 
Here, we briefly describe this novel experimental model of induced hypoxia and re-
aeration. Using this experimental model, we have collected a set of genomics profiling 
data that includes transcriptomics, metabolomics, proteomics, and lipidomics data sets. 
These data sets were collected in parallel over a 14-day time course that includes a 
transition from normoxia to hypoxia and a transition from hypoxia back to normoxia. We 
describe how the a method that integrates transcriptomics datasets with a genome-scale 
model of Mycobacterium tuberculosis is able to make accurate predictions about changes 
in metabolite concentration as well as changes in lipid production across the time course. 
Methods 
Strain and Culture Conditions 
The strain used in our experimental model of induced hypoxia andre-aeration was MTB 
H3 7R v and an experimental protocol similar to what was described in previous 
experiments to determine the enduring hypoxic response of MTB was implemented [3] as 
described previously [3,12,67]. Samples were extracted at time point 0 and then after 1, 
2, 3, 5, and 7 days of the induction of a hypoxic state (1% oxygen tension). At day 7, 
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cultures were returned to aerobic culture and samples were extracted at days 8, 9, 11, and 
14 (corresponding to 1, 2, 4, and 7 days subsequent tore-aeration respectively). Figure 16 
summarizes the collection protocol for the data utilized in this study . 
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Figure 16 In vitro infection model sampling scheme 
This schematic summarizes each experiment conducted using the in vitro model of 
hypoxia and re-aeration and the type of data collected. For each experiment, MTB 
was grown to an optical density (OD) of 0.4 in 7H9 media. Two days before the 
induction of hypoxia, cells were transferred to Sauton's medium in roller bottles 
and diluted to an OD of 0.2 in order to acclimate the cells to the new medium. At 
day 0, cells were transferred to spinner flasks and oxygen tension controlled via the 
flow of nitrogen into the heads pace of the culture vessels. After 7 days in hypoxia, 
cells were transferred back to roller bottles for re-aeration and cultured in aerobic 
conditions for 7 more days. Arrows indicate the type of data collected at each time 
point and the numbers in parentheses indicate the number of replicates collected 
during the experimental runs indicated to the right of the time course schematic. 
In all replicates, MTB was grown to sufficient biomass to facilitate multiple high-
throughput analyses. Prior to exposure to hypoxia, samples were grown in Middlebrook 
7H9 (Difco) supplemented with glycerol (0.2%), Tween-80 (0.05%), and ADC (Difco). 
Two days prior to the transfer of the cultures into hypoxic conditions, the cells were 
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pelleted and suspended in Sauton's medium without Tween-80 at an initial OD6oo of0.2 
and cultured for two days in aerobic conditions in roller bottles. Subsequently, samples 
were again diluted to an OD6oo of between 0.1 and 0.2 and transferred to spinner flasks. 
The flasks were spun in order to prevent clumping in the absence of a detergent 
supplement to the medium. Oxygen tendsion was maintained at 1% by flowing nitrogen 
into the headspace of the spinner flasks. After 7 days of hypoxic culture, samples were 
transferred back to roller bottles and cultured in aerobic conditions for 7 more days. 
Samples required for high-throughput analysis were collected at each time point. 
Importantly, our hypoxic cultures in Sauton's medium do not contain Tween-80 or an 
exogenous lipid source. Tween-80 is a detergent that is normally utilized to prevent 
clumping. The uniformity of culture that is introduced by Tween-80 is unlikely to reflect 
real physiological conditions. In addition, the lack of a significant change in the number 
of colony forming units generated from detergent-treated samples at each time point 
suggests that bacterial remain viable throughout the time course. M bovis bacillus 
Calmette and Guerin (BCG) has been shown to grow well on Tween-80 [83] and thus the 
elimination of this detergent also enables us to identify glycerol as the primary carbon 
source for this experiment. For several replicates, colony forming unit (CFU) 
measurements were taken and no significant decrease in CFU was measured, suggesting 
that in our experimental model there were not large-scale shifts in CFU or biomass 
production, although we did not take quantitative measurements ofbiomass. 
Our profiling data set consists of measurements of lipids, proteins, metabolites, and 
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mRNA. Raw data will be generated at several sampling cores set up to handle each 
experimental analysis method. Metabolomics profiling was performed in an untargeted 
manner by comparing ion spectra generated from the test samples to a known library of 
metabolic compounds. 
Gene expression data 
Gene expression data was collected using a custom 12-plex NimbleGen array (accessible 
with NCBI GEO accession number GPL14824). Each array on the slides consists of 105k 
probes tiled approximately every 100 bp over the genome. For our modeling purposes, 
we will focused our efforts on analyzing the transcriptomics data from experiments 2, 6, 
and 7 and the metabolomics data from experiments 6 and 7. 
Gene expression data were normalized using the oligo library [73], which is available for 
the R statistical software package [72]. This library implements previously-described 
single channel microarray analysis methods for background correction, quantile 
normalization, and RMA probe summarization [74] . 
Transcriptomics 
RNA was extracted from hypoxic and aerobic cultures at time points indicated by the 
pink arrows in Figure 16. In total, between 3 and 7 replicates were performed (depending 
on the time point) from which RNA was extracted. Total RNA was analyzed using a 
custom 12-plex NimbleGen array (accessible with NCBI GEO accession number 
GPL14824). Each array on the slides consists of 105k probes tiled approximately every 
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100 bp over the genome. Chips were hybridized and data collected as previously 
described [84]. Gene expression data were normalized using the oligo library [73], which 
is available for the R statistical software package [72]. This library implements 
previously-described single channel microarray analysis methods for background 
correction, quantile normalization, and RMA probe summarization [74]. 
Metabolomics 
Both M tuberculosis cell pellets extracted from our cell culture vessels and condition 
culture medium were extracted for analysis by our collaborators at Metabolon using 
several independent platforms: ultrahigh performance liquid chromatography/tandem 
mass spectrometry (UHPLC/MS/MS) optimized for basic species, UHPLC/MS/MS 
optimized for acidic species, and gas chromatography/mass spectrometry (GC/MS) [85]. 
In combination, these three platforms provides relative quantitation of a large number of 
metabolic species with high degree of confidence [86] . Metabolite extraction was 
performed by spinning cells into pellets and washing in 10 ml 2:1 chlorofonn:methanol. 
After incubating for 2 hours on a rotating platfonn at 37°C, the sample was dried tmder a 
nitrogen stream and frozen at -80°C. The medium was filtered twice on a 0.2 J.lm Steriflip 
unit. Further processing was conducted from sample aliquots following a previously-
described procedure that is specific to each platform [67,86] . 
Following mass spectrometry, metabolites were identified by comparing measured ion 
features against a reference library of chemical standards. Retention time, molecular 
weight (rn/z), preferred adducts, in-source fragments, and MS spectra were used to make 
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these identifications. Relative abundances for each identified metabolite were calculated 
by comparing peak areas under the curve for the ion species corresponding to each 
metabolite. 
Lipidomics 
Lipids were measured by D. Branch Moody's group using an untargeted lipidomics 
method using liquid chromatography high-mass accuracy mass spectrometry as 
previously described [67,87]. Briefly, cell pellets were subjected to a 
chloroform:methanol (2: 1) extraction, and lipid extracts were dried down and then 
subjected to a water wash by re-suspending total lipid in 6ml of chloroform:methanol 
(2:1) and 1ml ofwater (Fisher, HPLC grade). After centrifugation at 2000rpm for 15min, 
the water layer was removed and discarded to rid of contaminating glycerol extracted 
from the culture medium. Lipid extracts were weighed and 1 Of.lg of total lipid from each 
sample was injected onto a Varian Monochrom 3J.lm diol column (2xl50mm) and 
separated using an Agilent 1200 series HPLC with a starting mobile phase of 
hexanes:isopropanol (70:30) and an eluting mobile phase consisting of 
isopropanol:methanol (70:30). High-mass accuracy mass spectra were analyzed by an 
Agilent 6520 Accurate-Mass Q-ToF detector. We acquired data in both positive- and 
negative-ion modes, but focused on analyzing the positive-ion mode data as it included 
more lipid classes. The negative ion-mode data was used to corroborate the results. The 
raw data were analyzed by Agilent Mass Hunter Qualitative Analysis software (version 
B.03.01), and the data files exported as mzdata files. 
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Metabolic of metabolic models 
In order to analyze our high-throughput genomics data set, we utilize a modified version 
of the previously-described GSMN-TB model [ 19] that has been modified to reflect the 
current state of biochemical knowledge with respect to the metabolism of Mycobacterium 
tuberculosis. 
Integrating high-throughput data with our metabolic model 
For the following computational analyses, we utilized the GSMN-TB genome-scale 
metabolic model [19] with a method called probabilistic regulation of metabolism 
(PROM) [21] . This method is a modification of the traditional flux balance analysis 
approach, which is described in Equation 1, and the modified approach is described in 
Equation 3. The method was originally designed to make predictions based on the 
probabilistic inference of transcription factor-gene interactions and was validated on 
transcription factor essentiality data in both Escherichia coli and Mycobacterium 
tuberculosis. 
maximize Z - K(L;a + 2:/3) 
Subject to S · v = 0 
lb:::; v:::; ub 
lb'- a :::; v :::; ub' + f3 
Equation 3: probabilistic regulation of metabolism (PROM) 
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In Equation 3, lb' and ub' are modified flux bounds that are calculated from gene 
expression data in a way very similar to the previously described E-flux approach [29]. a 
and ,Brepresent slack variables that enable violation of the expression-derived flux 
constraints. The sum of these variables (and hence the violation of the expression-derived 
flux bounds) is minimized at the same time that the biological objective function is 
maximized. The resulting flux distribution thus represents a trade-off between these two 
objective types. The variable K represents the contribution of the constraint violation to 
the overall objective function. Higher values yield "harder" constraints. As K approaches 
higher values, the flux bounds will tend towards the absolute flux bounds of theE-flux 
approach. 
In order to calculate lb' and ub', we follow a slightly different procedure than the ones 
described in [75] and [21]. In those publications, the authors made use of the assumption 
of some minimal level of biomass production followed. We perform two analyses for 
comparison: one in which the modified bounds are created from the original bounds of 
the model and one in which the bounds are calculated using the FVA-based approach. 
The relationships between genes, proteins, and reactions in the model are represented by 
Boolean gene-protein-reaction (GPR) formulae. For some reactions, there is a one-to-one 
correspondence between genes and the gene product catalyzing that reaction. In these 
cases, we substitute the gene expression value directly for the reaction expression value. 
In order to utilize these Boolean formulae corresponding to enzyme complexes to 
calculate a continuous reaction-level expression from gene expression values we 
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incorporate convert AND relationships between genes to the minimum expression value 
of those two genes. We convert OR relationships the sum of the expressions of two 
genes. The rationale is that if two genes are required to form a complex for the function 
of a particular reaction, then the limiting gene is the gene with lower expression. For a 
reaction that can be catalyzed by multiple enzymes, the sum of the expression values is a 
more appropriate measure since any of the reactions corresponding to those enzymes may 
carry flux for that reaction. We follow an approach similar to that described in several 
previous approaches [29,32,75 ,88]. This method handles arbitrarily complex isozyme and 
enzyme complex relationships . 
In order to convert reaction-level expression values into relative expression values that 
can be applied to our estimated unconstrained flux bounds, we normalized expression 
values across the full hypoxia and re-aeration profiling time course by the maximum 
value across the time course for each reaction. Thus, when a reaction shows the highest 
expression level, it will remain unconstrained. This normalization was conducted to 
generate a set of comparable values across genes. 
In order to model the uncertainty in our gene expression values and their relationship to 
modeling predictions, we utilized a Monte Carlo sampling approach. For each gene at 
each time point we added values sampled from a Gaussian distribution centered on zero 
with a standard deviation calculated across the replicates. These samples were added to 
the log2 RMA expression values and subsequently exponentiated for reaction expression 
calculation. Similar approaches have been used previously in order to assess the 
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sensitivity of modeling results on the variance of gene expression data [29,75]. 
We also implemented a pennutation approach to assess the specificity of our results on 
the specific configuration of gene expression values measured in our profiling data set. 
Similar methods have been described previously [29,75,89]. We performed 1000 
permutations by randomizing the gene names of our expression data set and then 
I 
applying the resulting expression set to our model. 
Results 
Figure 17 shows an overview of a selection of the transcriptomics and metabolomics data 
integrated with a metabolic map that highlights several pathways that are suggested by 
the data to be differentially regulated during either the transition to hypoxia or during re-
aeration. In this figure, all values are differential abundance values taken relative to day 0 
(normoxia). Consistent with the results of previous experiments [23] , we see evidence in 
the transcriptional data of activation of the methylcitrate cycle during hypoxia and 
subsequent to re-aeration. The methylcitrate pathway catabolizes propionyl-CoA and 
oxaloacetate into pyruvate and succinate, which suggests an important role for the flux of 
propionate, a high-energy metabolite that is toxic to MTB when it accumulates inside the 
cell [90,91]. In addition, icl, the gene that in MTB codes for both isocitrate lyase and 
methylcitrate lyase, is up-regulated. There are three sources for propionate toxicity: the 
catabolism of odd chain and branched chain fatty acids, the metabolism of branched 
chain amino acids (BCAAs ), and the catabolism of cholesterol. In our experimental 
model, no exogenous sources of lipid or cholesterol are present in the medium. This 
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leaves two potential sources: branched chain amino acids generated during protein 
degradation, via novel synthesis of BCAAs, or via the degradation of endogenous lipid 
sources. 
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Figure 17 Summary of key results from the transcriptomics and metabolomics data 
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Figure 18 shows a summary of the lipidomics data generated during the time course. 
These plots represent eight lipid classes that show significant changes in abundance in 
response to changing oxygen tension. Importantly, we see rapid accumulation of 
triacylglycerol (TAG) after the transition to hypoxia followed by rapid utilization of TAG 
immediately after re-aeration. TAG production has been shown in previous studies to be 
very important for adaptation to hypoxia [44,80,92]. This storage lipid acts as a source of 
fuel that allows MTB to reactivate after periods of re-aeration. 
One question that might be addressed by our metabolic modeling method is the balance 
between diacylglycerides (DAG) utilization and TAG production. tgsl, the primary TAG 
synthase gene, is upregulated in hypoxia. However, genes upstream of this gene that code 
for genes responsible for fatty acids and DAG, a precursor to TAG, are actually down-
regulated. This suggests TAG production may result from a decrease in the utilization of 
the metabolite rather than an overall increase in production. This uncertainty makes these 
pathways important targets for a metabolic modeling approach. Because our method 
allows imbalances in the production or consumption of some metabolites, it will be well-
suited to address situations where imbalances in production and consumption lead to 
changes in metabolite abundances. These processes are important because they have 
implications for the ability of MTB to reactivate after periods of periods of dormancy 
such as those experienced during infection. If we were able to disrupt the mobilization of 
these resources, we might be able to disrupt re-activation and the return to a replicative 
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state. 
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Predicting changes in intracellular metabolite concentration with flux balance analysis 
In order to address some of the questions raised by our interpretation of the experimental 
data, we have implemented a metabolic modeling technique based on flux balance 
analysis (FBA) in an effort to predict changes in intracellular metabolite predictions . This 
analysis acts as a validation ofboth FBA and the probabilistic regulation of metabolism 
(PROM) approach for integrating expression data with genome scale metabolic models . 
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Figure 19 Predictions of changes in concentration after the introduction of hypoxia (day 1 
vs. day 0) 
The change in maximum flux through each metabolite measured in our metabolomics data 
is plotted against the log2 fold change in concentration (day 1 vs. day 0). Predictions are 
generated using the scheme illustrated on the right hand side of this figure. 800 samples 
were generated using the Monte Carlo approach described in the methods. Error bars 
represent standard deviations of predicted changes are calculated across the 800 samples 
and across 4 replicates in the case of experimental measurements. 
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Figure 19 shows the results of the application of our method using gene expression data 
collected both immediately before and immediately after the introduction of hypoxia in 
our experimental model. We measure a Pearson correlation between measured expression 
changes and predicted changes in flux of0.67 (p-value = 8.37e-9) and a Spearman (rank) 
correlation of 0.46 (p-value = 1.89e-5), meaning we achieve statistically significant 
correlations between measurements and predictions. If we compare only statistically-
significant predictions and measurements, we calculate a Matthews correlation 
coefficient of0.83 (hypergeometric p-value < 0.001). The Matthews correlation 
coefficient is a correlation coefficient suitable for binary prediction data even in data sets 
with unbalanced classes. Here, we consider whether the sign of a change in flux is 
predictive of the sign of the change in concentration, an approach used in previous work 
on comparing flux modeling predictions and changes in concentration [36] . Thus, even in 
the absence of detailed kinetic parameters for each reaction and the lack of quantitative 
concentration measurements, we are able to accurately predict changes in concentration 
after the induction ofhypoxia. If we compare day 7 of hypoxia to day 0 we see similar 
agreement (Figure 20). 
Interestingly, in agreement with the observations of Reznik, Mehta and Segre, many of 
the disagreements between our predictions and the experimental data are for metabolites 
involved in amino acid synthesis and degradation pathways [36]. As suggested by the 
authors, this may be due to a general inconsistency between the change in concentration 
of metabolites in those pathways and gene expression data. This may also be due to our 
use of an objective function that fixes the stoichiometries of different amino acids in 
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order to represent protein synthesis. This may decrease our ability to capture changes in 
abundance of individual amino acids. 
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Figure 20 Predictions of changes in concentration after the introduction of 
hypoxia (day 7 vs. day 0) 
The x-axis shows the predicted change net production for each metabolite. The y-
axis shows the log2 fold change in concentration for each of the metabolites that 
we have represented in our model. The Matthews correlation. coefficient for this 
comparison is 0.64, which is statistically significant (p < 0.001). 
In order to test whether our predictions are due to the specific configuration of gene 
expression and the metabolites that we are testing or whether the overall trend in the 
expression of a large set of genes, we compared the predictions of our model with 
predictions generated from a set of models to which gene expression with randomized 
gene labels was applied. Gene labels were randomized and the entire time course for each 
randomized set of gene labels was applied. 800 replicates of the data were constructed 
like this and the distribution of Matthews correlation coefficients was compared to the 
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distribution of Pearson correlation coefficients generated form the sampled expression 
data with true gene names described previously. These results are shown in Figure 21. 
Importantly, one of the metabolites that we correctly predict to accumulate is succinate. 
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Figure 21 Distributions of Matthews correlation coefficient for permutation data 
and sampled data (day 1 vs. day 0) 
In order to generate permutation data, we followed the procedure described in the 
schematic on the left. We generated 800 samples by randomizing gene labels on 
the time course expression data. Matthews correlation coefficients are calculated 
for each permutation. This distribution is compared with the distribution of 
coefficients generated from the Monte Carlo sampling replicates. True data shows 
much better performance than random models on the test data set. 
Recent efforts at understanding metabolic adaptation of MTB to hypoxia have 
highlighted the important role that succinate secretion plays in maintaining an energized 
membrane and to alleviate reductive stress via fermentation [93,94]. Watanabe et al. 
identified the operation of the reductive TCA cycle in the production of succinate but 
identify succinate production via propionate metabolism and the methylcitrate cycle [93]. 
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Our predictions indicate that, in fact, the latter model for succinate production is active in 
our experimental model. This would seem to confirm the model of Eoh et al., which 
suggests that in addition to their role in lipid metabolism via the glyoxylate shunt, the two 
ICL paralogs of MTB are also responsible for the generation of succinate in effort to 
sustain MTB through the latent hypoxic phase [94]. We observe increased levels of 
malate and aspartate throughout hypoxia Figure 22 suggesting a role for glyoxylate 
shunt-based TCA in the production of succinate. Interestingly, we also predict the same 
large difference between succinate secretion and isocitrate and citrate secretion, 
suggesting that we are capturing the combined roles of the glyoxylate shunt and the 
methylcitrate cycle in the adaptation to hypoxia. 
Predicting changes in lipid production during hypoxia and re-aeration 
As a final validation of the ability of our model to make predictions about changes in 
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Figure 22 Predicted changes in succinate, malate, aspartate, and citrate 
production after the introduction of hypoxia 
lipid metabolism, we looked at a separate set of lipidomics data. This experimental data is 
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plotted in Figure 18. Table 2 shows a comparison of our metabolic modeling results with 
the measured data. We conectly predict that majority of changes in the measured 
metabolite classes. Our model inconectly predicts one change: a decrease in the 
concentration of sulfolipids where we measure no change in our experimental data. 
---------~----------- ----------- ·---- ---------------------------
Hypoxia Re-aeration Function 
- ------------ ---· - ----------------- - ------
Triacylglycerol Up Down Energy storage 
Sulfolipids No change Up lmmunomodulatory 
Trehalose moriomycolates Down Up Cell 
wall/immunomodulatory 
Trehalose dimycolates Down Up Cell 
wall/immunomodulatory 
Phosphat idyl Down Up 
ethanolamine 
Phthiocerol Down Up {day 11) lmmunomodulatory 
dimycocerosates 
Table 2 Measured lipid changes and lipid functions 
Each class of lipid that we have measured and for which is represented in our model 
are shown in this table. The direction of the change in intracellular concentration of 
each lipid is indicated as 'Up' or 'Down'. The only change that we predict 
incorrectly across both the hypoxic and re-aeration transitions is highlighted in 
coral. In our model, we predicted strong down-regulation of sulfolipid production 
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I 
In our experimental data, the expression of genes corresponding to sulfolipids and 
methylmalonyl are generally down-regulated. This down-regulation is reflected in the 
predictions of our model, but not in lipidomics data. This may be because the species we 
measure is a diacylated sulfoglycolipids (AC2SGL), a precursor to SL-1. This 
discrepancy may be due to a lack of detail in our model in the representation of the 
production of sulfolipid precursors. Nevertheless, we do correctly predict the change in 
concentration of branched chain lipids. 
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Figure 23 Comparison of predicted TAG production and measured TAG production 
The upper panel re-capitulates the gene expression and metabolomics data of genes and 
metabolites associated with TAG. The expression of tgsl (the main triacyglyceide synthase) 
remains constant into hypoxia and decreases after re-aeration (indicated by a vertical line 
in the box marked tgsl. In this plot, red is high expression and blue is low expression. One 
of the main precursors for TAG is glycerol-3-phosphate (G3P). Lipids and G3P are 
incorporated into diacylglycerides and triacylglycerol. Our model correctly predicts TAG 
accumulation during hypoxia and utilization after re-aeration. 
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Importantly, we also correctly predict an increase in the production oftriacylglycerol 
(TAG). TAGs are storage lipids that have been shown to be required for the re-activation 
of BCG after exposure to hypoxia [ 45]. A recent study showed the role ofT AG 
production for growth-limitation and antibiotic resistance in hypoxia [ 44]. The 
modulation ofthe production of this lipid is thus an important target for study. 
Figure 23 shows both the measured abundance of each class of triacylglycerol measured 
in our lipidomics data set. Our model, in combination with the PROM method, correctly 
predicts a large accumulation of TAG during hypoxia and the rapid re-utilization of TAG 
following re-aeration. Thus, we capture an important aspect of the metabolic adaptation 
ofMTB to hypoxic conditions. In a recent study, Baek et al. studied the role that a switch 
from flux through TCA to a flux through TAG plays in the adaptation to hypoxia [44]. 
Stress (hypoxia. low Fe, low pH etcl 
l 
DosR 
\ 
~Tn 
tolerance 
Figure 24 Model for the modulation of 
antibiotic tolerance by the production of TAG 
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Figure 24 shows the model proposed by Baek et al. for the regulation of antibiotic 
tolerance through the regulation ofT AG production. During normal aerobic growth, 
MTB is susceptible to the introduction of antibiotics into the medium. TAG production is 
induced via the regulation of DosR in response to stresses commonly seen during 
infection, including hypoxia, low iron levels, and low pH. tgs 1 knockout mutants increase 
the rate of growth ofMTB and increase susceptibility to antibiotics. In addition, the 
introduction of oxaloacetate to the medium stimulates TCA even during hypoxia, 
drawing flux away from TAG synthesis and into central metabolism, which also 
increases antibiotic susceptibility [ 44]. 
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An outstanding question presented by our data and other work into the production of 
TAG is the relative effect of increases in production versus decreases in utilization in the 
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accumulation ofTAG during exposure to inducing stresses. Figure 25 shows the changes 
in both the production and consumption fluxes of triacylglycerol over time. Interestingly, 
changes in triacylglycerol accumulation appear to be largely driven by changes in the 
consuming fluxes of triacylglycerol. This is in line with the dual role that TAG appears to 
play during they hypoxic adaptation: (1) ass sync for reducing equivalents and for carbon 
flux that would otherwise flow through TCA and (2) as an energy store that can be 
rapidly mobilized after the re-introduction of oxygen to the medium. In light of the 
predictions of our model and the corresponding expression data, it would appear that the 
role of dosR, at least in our experimental model, is not to induce the production of 
triacylglycerol but possibly to maintain the level of expression oftgsl in the context of a 
general decrease in metabolic activity. 
In light of our predictions about changes in the accumulation of TAG, we sought to see if 
we could provide a regulatory explanation for changes on the demand side of the 
production ofthis lipid. Much of the experimental work on latency and on TAG 
production in particular has focused on the role of dosR in the regulation of TAG 
production [3,84,95]. Using our metabolic model, we searched for reactions that, when 
knocked out, decrease the optimal flu:x through TAG degradation pathways by more than 
50%. We then identified genes associated with these reactions that are both down-
regulated and are associated with binding in our transcriptional regulatory network 
model. This process appears to be driven largely by down-regulation of the acyl-CoA 
dehydrogenases that catabolize fatty acids cleaved from triacylglycerol. 
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LJ l~J 
--- repression 
--- activation 
Figure 26 A regulatory module predicted to link dosR to the 
degradation of triacylglycerol 
Red links indicate activation according to the direction of regulation in 
an overexpression experiment. Blue links indicate repression. dosR 
expression is predicted to induce the expression of dosR, which 
downregulates Rv1816 and its targets Rv1070c and Rv1071c, which are 
an acyl-CoA dehydrogenase (FadEl) and acyl-CoA hydratase 
respectively. 
Figure 26 shows a regulatory module identified by the approach described above. The P-
oxidation genes Rv1070c and Rv1071c, which are an acyl-CoA dehydrogenase (FadEl) 
and acyl-CoA hydratase respectively. These genes are important for the degradation of 
fatty acids and predict a novel role for the hypoxic response and lipid production 
regulator. Thus, our model predicts a role for DosR in the regulation of not only 
triacylglycerol production via the upregulation of the expression of the triglyceride 
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synthase tgsl, but also in the regulation of the degradation of the lipid components of 
triacylglycerol. Furthennore, this regulation is predicted to happen along with the 
regulation by DosR of the production of PDIM, an important virulence lipid whose 
production is down-regulated during hypoxia. 
Conclusions 
In this chapter, we build on our work of the previous chapter in order to test our ability to 
model changes in lipid production during hypoxia andre-aeration. We show that our 
method is able to accurately predict changes in intracellular metabolites and the 
production ofvirulence lipids using a set of recently-reported high-throughput omics data 
sets [67]. Our model predicts the utilization of both the methylcitrate cycle and the 
glyoxylate shunt in order to produce succinate, which is in line with recent observations 
of the importance of succinate secretion in maintaining an energized membrane for low-
level production of A TP in MTB during periods of hypoxia [93 ,94] . Our prediction of the 
accumulation oftriacylglycerol is in line with experimental measurements. Our model 
suggests that this accumulation is due to a decrease in the consumption of TAG due to a 
down-regulation genes in the ~-oxidation pathway while the expression of the main 
triglyceride synthesis tgs l is held at a high level by the regulatory activity ofDosR. 
Interestingly, when looking at binding predictions that could explain this decrease in lipid 
degradation, we find down-regulated genes that are strongly-regulated by a submodule 
controlled by the expression of DosR. This presents a novel role for DosR in the 
regulation of lipid degradation. In combination with the role that DosR is predicted to 
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play in the regulation of PDIM synthesis, this work suggests a role for DosR greatly 
expanded beyond that currently understood in the literature and presents several novel 
regulatory interactions for future validation. 
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CONCLUSIONS AND FUTURE DIRECTIONS 
Metabolic models of Mycobacterium tuberculosis 
The overall goal of this work was to demonstrate the efficacy of integrating high-
throughput data sets with metabolic models of Mycobacterium tuberculosis . In order to 
accomplish this, we modified the GSMN-TB model of Beste et al. [19]. We modified this · 
model in order to more closely represent the most recent state of knowledge of the 
biochemistry and genetic regulation of lipid metabolism. The importance of lipid 
metabolism in in vivo and in vitro models of infection is supported by studies into the role 
that phthiocerol dimycocerosate, sulfolipid, triacylglycerol, mycolates, and other lipids 
[ 46,49-51 ,80,82,96,97] . In addition, the ability of MTB to consume and degrade 
cholesterol is important for survival during infection [52,53,55,58,59,98]. The importance 
of these improvements is highlighted by the accuracy of the model in predicting 
cholesterol genes important for cholesterol metabolism Table 2 and the accuracy of the 
model when predicting changes in lipid metabolism during hypoxia andre-aeration Table 
2. 
While much progress has been made in recent years in elucidating lipid production 
pathways, many of these pathways have yet to be fully specified. The MTB genome is 
rich in genes predicted to take part in lipid metabolism [99] . The assignment of specific 
lipid production or degradation genes to specific pathways has been difficult. Hence, the 
connection between specific metabolites in the metabolic model and specific genes and 
proteins is unclear. For example, in a study on the functional FadE proteome ofMTB, 
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only a fraction ofthe annotated FadE proteins were shown to be functional [100]. 
Nevertheless, recent efforts at manual re-annotation [65] and condition-specific high-
throughput essentiality studies [59,63] have continued to improve our ability to 
accurately represent the lipid biology ofMTB. 
Elucidating the transcriptional regulation of lipid metabolism 
Utilizing the PROM method and our improved version ofGSMN-TB, we validated our 
model by accurately predicting changes in the production of lipids in dosR and phoP 
knockout strains. We also accurately predict the induction of the production of 
triacylglycerol as the main perturbed lipid in a dosR overexpression experiment. The 
accuracy of these predictions suggest that integrating transcriptomics data with GSMN-
TB provides a useful framework for understanding the biology of Mycobacterium 
tuberculosis and for the prediction of changes in lipid metabolism in particular. 
By combining our predictions with those of a recently-reported binding network [67], we 
are able to suggest a novel regulatory role for the transcription factor DosR in the 
production of PDIM, an important virulence lipid. Our model suggests that DosR may 
control a metabolic switch that is important for the transition of MTB from fast growth to 
slow growth via the switch from carbon flux into triacylglycerol, which has been shown 
to be important for antibiotic resistance during hypoxia [ 44]. The regulatory role for 
DosR in increasing production oftriacylglycerol (TAG) is well known [81], the potential 
role for DosR in the regulation of other lipids after the introduction of hypoxia is 
unexplored. These predictions will need to be validated and other connections between 
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DosR and lipid production and degradation that are suggested by the metabolic and 
regulatory networks will need to be explored. 
Metabolic adaptation to hypoxia 
Using an improved model of Mycobacterium tuberculosis, we looked at our ability to 
predict metabolic adaptations to hypoxia and re-aeration. We show that our method is 
able to accurately predict changes in intracellular metabolites and the production of 
virulence lipids using a set of recently-reported high-throughput ornics data sets [67]. Our 
model suggests that succinate production is important during hypoxia, which suggests 
that our experimental and computational models capture changes known to be important 
for maintaining an energetic membrane in the absence of oxygen as a terminal electron 
acceptor [93,94]. 
We also predict a novel regulatory role for DosR in the degradation oftriacylglycerol. In 
combination with the prediction ofDosR as a regulator ofPDIM production during 
hypoxia, our model and our expanded binding network predict a greatly-expanded role 
for DosR in the regulation oflipid metabolism in MTB. We are currently in the process 
of validating the importance of the DosR regulatory connections described in this work. 
In addition, further work is necessary to expand the number of transcription factors for 
which we have genome-scale binding predictions and in assigning genes important for 
lipid production and degradation to appropriate pathways. In parallel, these efforts will 
set the groundwork important for expanding our ability to make computational 
predictions about metabolic and transcriptional adaptations that occur as a result of 
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metabolic perturbations that mimic those seen during infection. 
Conclusion 
Here, we present a metabolic model and modeling framework that are able to accurately 
model changes in lipid metabolism in hypoxia and re-aeration. We also present novel 
predictions of metabolic adaptations and transcriptional regulation that suggest a greatly 
expanded role for the hypoxia and lipid transcriptional regulator DosR. This builds on an 
increasing body of work that suggests the importance of integrating high-throughput 
genomics data sets in order to improve the accuracy of metabolic predictions. This is 
important because of the difficulty of working with experimental models ofMTB. 
Accurate in silica predictions greatly increase the speed with which we can increase our 
knowledge of the basic biology ofMTB and possibly our ability to test novel 
antimicrobials that can be target towards the treatment of this pathogen. Importantly, this 
approach is applicable not only to Mycobacterium tuberculosis. Expanding use of high-
throughput genomics techniques in organisms like Plasmodium falciparum will allow for 
the use of techniques like the one described in this work to expand our knowledge of 
large classes of pathogenic organisms. 
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